These results indicate that un‐cured mice have fewer types of TCR and BCR in the blood and spleen, and this decrease in diversity is probably due to the increase in only a few dominant TCR, which limits the capacity to recognize more diverse antigens in tumor cells. The gene discussed is BCR; the disease is neoplasm.